Syschem (India) Limited Rights Issue (Syschem India Rights Issue 2023) Detail

₹31.89 Crores | Listing at BSE | Mon, Oct 16, 2023 - Fri, Oct 27, 2023

Syschem (India) Limited Logo

Syschem (India) Limited Rights Issue comprises 0.7973 Cr equity shares aggregating to ₹31.89 Cr, offered at an issue price of ₹40 per share with a face value of ₹10 per share.

The record date for determining eligible shareholder is Sep 29, 2023, with the Rights Issue being offered in the entitlement ratio of 1 : 4.

The term of payment is defined as following : The full amount of Rs. 40/- per equity shares is payable on application.

The Rights Entitlements are expected to be credited to eligible demat accounts on [.]

The Rights Issue opens on Oct 16, 2023, and closes on Oct 27, 2023, with renunciation of Rights Entitlements permitted up to Oct 23, 2023.

The deemed date of allotment is Nov 4, 2023, following which the equity shares are expected to be credited to demat accounts on Nov 8, 2023 and listed at the BSE on Nov 13, 2023.

Beetal Financial & Computer Services Pvt.Ltd. is the Registrar to the Issue.

Investors are advised to refer to the Syschem (India) Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.

Record Date

Fri, Sep 29, 2023

Entitlement Ratio

1 : 4

Open Date

Mon, Oct 16, 2023

Close Date

Fri, Oct 27, 2023

Rights Issue Details

Rights Issue Timetable

Syschem (India) Limited Financial Information (Restated)

Syschem (India) Limited's revenue decreased by -54.56% and profit after tax (PAT) dropped by -69.23% between the financial year ending with July 31, 2023 and March 31, 2023.

Period Ended31 Jul 202331 Mar 202331 Mar 202231 Mar 2021
Assets93.0492.7159.8177.17
Revenue59.36130.6365.7674.67
Profit After Tax1.394.51-1.71-5.57
Net Worth23.6922.306.947.12
Reserves and Surplus
Total Borrowing1.521.611.7512.56
Amount in ₹ Crore

About Syschem (India) Limited

Incorporated in 1993, Syschem (India) Limited is engaged in the manufacturing of Bulk Drugs, Intermediates, Specialty Chemicals, and contract manufacturing.

The company's product portfolio includes Amoxycillin Trihydrate, Ampicillin Trihydrate, Cloxacillin Sodium, Dicloxacillin Sodium, Flucloxacillin Sodium, Oxacillin Sodium, Cefalexin Monohydrate, Cefadroxil Monohydrate, and Cefaclor.

Syschem (India) is among the very few research-driven API manufacturing companies in India that provide customized solutions at a commercial scale. Its clientele comes from domestic as well as International markets.

The company is headquartered in Chandigarh and has Manufacturing facilities located at Kalka, Panchkula (Haryana).

Objects of the Issue:

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  1. To Expand the existing manufacturing facility for manufacturing of Amoxicillin and Cephalexin at unit located at Village Bargodam, Tehsil Kalka, Dist Panchkula, Haryana.
  2. Working capital requirements.
  3. General Corporate Purposes and Issue Expenses.

Rights Issue Review

[Dilip Davda] SIL has turned the corner in FY23 and is embarking upon expansion plans. The RI appears to have been priced greedily. Based on its recent financial performance, it is poised for bright prospects ahead. However, well-informed/cash surplus investors may consider parking funds for long-term rewards. Read detail review...

Rights Issue Subscription Status

Syschem India Rights Issue 2023 got oversubscribed by 1.48 times by the end of the bidding period with total bid quantity received by BSE of 1,18,16,309 shares. Check Day by Day Subscription Details (Live Status)

DateBSE Bid Quantity Subscription Times

Oct 27 2023 17:00:00

1,18,16,309

1.48x

Company Contact Information

Syschem (India) Limited
Village Bargodam,
Tehsil Kalka
Dist Panchkula - 133302
Panchkula, Haryana, 133302

Rights Issue Registrar

Beetal Financial & Computer Services Pvt.Ltd.

Rights Issue FAQs

The Syschem India Rights Issue 2023 opens on Mon, Oct 16, 2023, and closes on Fri, Oct 27, 2023.

Syschem India Rights Issue 2023 Schedule

Last Date for credit of Rights Entitlements
Last Date for renunciation of Rights EntitlementsMon, Oct 23, 2023
Issue Opening DateMon, Oct 16, 2023
Issue Closing DateFri, Oct 27, 2023
Date of Allotment (on or about)Sat, Nov 4, 2023
Date of Credit (on or about)Wed, Nov 8, 2023
Date of Listing (on or about)Mon, Nov 13, 2023
Syschem India Rights Issue 2023 price is set at ₹40 per share.
The eligible shareholders are being offered 1 Rights Equity Share(s) for every 4 fully paid-up Equity Shares held on Record Date (Fri, Sep 29, 2023).
The record date for the Syschem India Rights Issue 2023 is Fri, Sep 29, 2023.
The issue size of Syschem India Rights Issue 2023 is of 79,72,600 equity shares at ₹40 per share aggregating up to ₹31.89 Crores.
The Letter of Offer for Syschem India Rights Issue 2023 can be downloaded here.

You can apply for Syschem India Rights Issue 2023 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Syschem India Rights Issue 2023 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Syschem India Rights Issue 2023 is available on the list.
  4. Click the Apply button next to the Syschem India Rights Issue 2023.
  5. Fill and check your information.
  6. Submit the application.

Steps to apply for Syschem India Rights Issue 2023 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Syschem India Rights Issue 2023 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

Compare: